Altimmune ALT Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $400.72M.
The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Altimmune's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Altimmune's market capitalization?
- Altimmune (ALT) reported market capitalization of $400.72M in Q1 2026.
- How has Altimmune's market capitalization changed year-over-year?
- Altimmune's market capitalization increased by 4.1% year-over-year, from $385.07M to $400.72M.
- What is the long-term trend for Altimmune's market capitalization?
- Over 5 years (2020 to 2025), Altimmune's market capitalization has grown at a -3.4% compound annual growth rate (CAGR), from $448.25M to $376.68M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.